Investigating the shared genetic basis of inflammatory bowel disease and systemic lupus erythematosus using genetic overlap analysis
- PMID: 39285290
- PMCID: PMC11406968
- DOI: 10.1186/s12864-024-10787-0
Investigating the shared genetic basis of inflammatory bowel disease and systemic lupus erythematosus using genetic overlap analysis
Abstract
Background: Inflammatory bowel disease (IBD) and systemic lupus erythematosus (SLE) are autoimmune diseases that often coexist clinically. This phenomenon might be due to shared genetic components.
Methods: Genome-wide association study (GWAS) data for IBD and SLE were analyzed to determine both global and local genetic correlations using three methodologies: linkage disequilibrium score regression (LDSC), genetic covariance analyzer (GNOVA), and SUPERGNOVA. The genetic overlap and risk loci were subsequently examined using the conditional/conjunctional false discovery rate (cond/conjFDR) statistical framework. Furthermore, a multi-trait analysis of MTAG was employed to validate the loci, followed by an LDSC analysis focusing on tissue-specific gene expression.
Results: GWAS findings demonstrated a marked global genetic correlation between IBD (including Crohn's disease and ulcerative colitis) and SLE. Locally, SLE showed a strong association with IBD and Crohn's disease on chromosomes 10, 19, and 22. ConjFDR analysis confirmed the genetic overlap and identified relevant genetic risk loci. MTAG further validated several shared susceptibility genes. Additionally, the LDSC-SEG analysis results indicate that IBD (including CD and UC) and SLE are jointly enriched in the tissues of Spleen and Whole Blood.
Conclusion: This study confirms a genetic overlap between IBD and SLE, identifying marked comorbid genes and offering new insights for treating these diseases.
Keywords: Genetic overlap; Genetic risk loci; Genetic structure; Inflammatory bowel disease; Systemic lupus erythematosus.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchimol EI, Panaccione R, Ghosh S, Wu JCY, Chan FKL, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390:2769–78. 10.1016/S0140-6736(17)32448-0. - PubMed
-
- Hodson R. Inflammatory bowel disease. Nature. 2016;540:S97. 10.1038/540S97a. - PubMed
-
- Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99:1051–62. 10.1016/j.suc.2019.08.001. - PubMed
-
- Shor DB-A, Dahan S, Comaneshter D, Cohen AD, Amital H. Does inflammatory bowel disease coexist with systemic lupus erythematosus? Autoimmun rev. 2016;15:1034–7. 10.1016/j.autrev.2016.07.027. - PubMed
MeSH terms
Grants and funding
- Grant No. 82160903/National Natural Science Foundation of China
- (Jiangxi Traditional Chinese Medicine Science and Education No. [2022]7/Training Program for Young and Middle-aged Backbone Talents of Traditional Chinese Medicine (the fourth batch) of Jiangxi Province
- 2022Z005/Key Project of Science and Technology Plan of Jiangxi Provincial Administration of Traditional Chinese Medicine
LinkOut - more resources
Full Text Sources
Medical